# A Method to Evaluate Glucose-Dependent Insulin Secretion in Healthy Males (MK-0431-179)

> **NCT00888238** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 12 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** sitagliptin
- **DRUG:** Comparator: Placebo

## Key facts

- **NCT ID:** NCT00888238
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05-12
- **Primary completion:** 2009-06-10
- **Final completion:** 2009-07-21
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2018-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00888238

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00888238, "A Method to Evaluate Glucose-Dependent Insulin Secretion in Healthy Males (MK-0431-179)". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT00888238. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*